Cerebral Palsy

Upper limb function after intrathecal baclofen treatment in children with cerebral palsy
BACKGROUND: The literature shows that intrathecal baclofen (ITB) treatment in patients with cerebral palsy (CP) is able to reduce spasticity.

Milan, Italy
Italy
Spasticity treatment with botulinum toxins
Spasticity is a physiological consequence of an insult to the brain or spinal cord, which can lead to life-threatening, disabling and costly consequences.


UK
Is cerebral palsy preventable?
PURPOSE OF REVIEW: To use evidence of good medical quality to update information on strategies for prevention of cerebral palsy, and on the success of these preventive efforts to date.

Bethesda, MD 20892-2540
USA
Comorbidities and clinical determinants of outcome in children with spastic quadriplegic cerebral pa
The objective of this study was to determine the major comorbidities in patients with spastic quadriplegic (SQ) cerebral palsy (CP) and their possible clinical associations.

Montreal, Quebec
Canada
Cerebral Palsy
Extreme prematurity confers about a 100-fold increase in the risk of cerebral palsy (CP), relative to birth at term gestation.

Winston-Salem, NC 27157
USA
Randomized trial of botulinum toxin injections into the salivary glands to reduce drooling in childr
The primary aim of this randomized, controlled trial was to assess the effectiveness of botulinum toxin A (BoNT-A) injections into the submandibular and parotid glands on drooling in children with cerebral palsy (CP) and other neurological disorders.

Victoria, Australia
Australia